Clinical Trial Update: MultiStem® for Treatment of Trauma Induced Multiple Organ Failure/Systemic Inflammatory Response Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for MultiStem investigating treatment of trauma-induced multiple organ dysfunction syndrome and systemic inflammatory response syn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Organ Dysfunction Syndrome
• Systemic Inflammatory Response Syndrome

Drugs mentioned

• MultiStem (mesenchymal-like stem cell product)

Snippet

Sponsor: Healios K.K. | Conditions: Trauma, Adult Stem Cells | Phase 2 | Status: RECRUITING